This product is for research use only, not for human use. We do not sell to patients.

Size | Price | Stock |
---|---|---|
5mg | $180 | To Be Confirmed |
10mg | $290 | To Be Confirmed |
Cat #: V18061 CAS #: 145915-60-2 Purity ≥ 99%
Description: CGP-53353 (DAPH-7) is a potent PKC inhibitor (antagonist) with IC50s of 0.41 μM and 3.8 μM for PKCβII and PKCβI, respectively. CGP-53353 can inhibit glucose-induced cell growth/proliferation and DNA synthesis in AoSMC and A10 cells. CGP-53353 may be utilized to study atherosclerosis in patients with diabetes.
Publications Citing InvivoChem Products
Product Promise

- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 365.34 |
---|---|
Molecular Formula | C20H13F2N3O2 |
CAS No. | 145915-60-2 |
Storage | Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Synonyms | CGP-53353; CGP 53353; CGP53353 |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.7372 mL | 13.6859 mL | 27.3718 mL | 54.7435 mL |
5mM | 0.5474 mL | 2.7372 mL | 5.4744 mL | 10.9487 mL |
10mM | 0.2737 mL | 1.3686 mL | 2.7372 mL | 5.4744 mL |
20mM | 0.1369 mL | 0.6843 mL | 1.3686 mL | 2.7372 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.